A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response

SIMPLE SUMMARY: Pancreatic cancer (PC) is characterized by an exceptionally aggressive tumor biology, high inter- and intratumor heterogeneity, and resistance to conventional chemotherapy, targeted agents, and immunotherapy. With its rising incidence and dismal prognosis, PC is projected to become t...

Descripción completa

Detalles Bibliográficos
Autores principales: Beutel, Alica K., Schütte, Lena, Scheible, Jeanette, Roger, Elodie, Müller, Martin, Perkhofer, Lukas, Kestler, Annika M. T. U., Kraus, Johann M., Kestler, Hans A., Barth, Thomas F. E., Lemke, Johannes, Kornmann, Marko, Ettrich, Thomas J., Gout, Johann, Seufferlein, Thomas, Kleger, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196829/
https://www.ncbi.nlm.nih.gov/pubmed/34064221
http://dx.doi.org/10.3390/cancers13112539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196829/
https://www.ncbi.nlm.nih.gov/pubmed/34064221
http://dx.doi.org/10.3390/cancers13112539

Ejemplares similares